Homocysteine, estrogen and cognitive decline

References

• Panza F, D'Introno A, Colacicco A, et al. Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol Aging 2005, in press
   Web of Science ®Google Scholar
• National Centre for Health Statistics. Centers for Disease Control and Prevention. US Department of Health and Human Services. 2002, (Report)
   Google Scholar
• Cassidy K, Kotynia-English R, Acres J, Flicker L, Lautenschlager N T, Almeida O P. Association between lifestyle factors and mental health measures among community-dwelling older women. Aust N Z J Psychiatry 2004; 38: 940–947
   PubMed Web of Science ®Google Scholar
• Ott A, Anderson K, Dewey M E, et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology 2004; 62: 920–924
   PubMed Web of Science ®Google Scholar
• Fillit H M, Butler R N, O'Connell A W, et al. Achieving and maintaining cognitive vitality with aging. Mayo Clin Proc 2002; 77: 681–696
   PubMed Web of Science ®Google Scholar
• Stampfer M J, Kang J H, Chen J, Cherry R, Grodstein F. Effects of moderate alcohol consumption on cognitive function in women. N Engl J Med 2005; 352: 245–253
   PubMed Web of Science ®Google Scholar
• Singh-Manoux A, Richards M, Armot M. Leisure activities and cognitive function in middle age: evidence from the Whitehall II study. J Epidemiol Community Health 2003; 57: 907–913
   PubMed Web of Science ®Google Scholar
• McEwen B S. Estrogen action throughout the brain. Recent Prog Horm Res 2002; 57: 357–384
   PubMedGoogle Scholar
• Jaffe A B, Toran C D, Greengard P, Gandy S E. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem 1994; 269: 13065–13068
   PubMed Web of Science ®Google Scholar
• Whitehead M. Progestins and androgens. Fertil Steril 1994; 62: 1615–1675
   Google Scholar
• Jacobs D M, Tang M -X, Stern Y, et al. Cognitive function in nondemented older women who took estrogen after menopause. Neurology 1998; 50: 368–373
   PubMed Web of Science ®Google Scholar
• Rice M M, Graves A B, Amy B, et al. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project. Arch Intern Med 2000; 160: 1641–1649
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269: 2637–2641
   PubMed Web of Science ®Google Scholar
• Miller K, Conney J, Rasgon N, Fairbanks L, Small G. Mood symptoms and cognitive performance in women estrogen users and nonusers and men. J Am Geriatr Soc 2002; 50: 1826–1830
   PubMed Web of Science ®Google Scholar
• Maki P, Zonderman A, Resnick S. Enhanced verbal memory in nondemented elderly women receiving hormone replacement therapy. Am J Psychol 2001; 158: 227–233
   Web of Science ®Google Scholar
• Henderson V, Benke K, Green R, Cupples L, Farrer L. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry 2005; 76: 103–105
   PubMed Web of Science ®Google Scholar
• Zandi P P, Carlson M C, Plassman B L, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002; 288: 2123–2129
   PubMed Web of Science ®Google Scholar
• Rapp S, Espeland M, Shumaker S, et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women. JAMA 2003; 289: 2663–2672
   PubMed Web of Science ®Google Scholar
• Miller A L. The methionine-homocysteine cycle and its effects on cognitive diseases. Alternative Med Rev 2003; 8: 7–19
   PubMedGoogle Scholar
• Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476–483
   PubMed Web of Science ®Google Scholar
• Albert C M, Ma J, Rifai N, Stampfer M J, Ridker P M. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002; 105: 2595–2599
   PubMed Web of Science ®Google Scholar
• Graham I, Daly L, Refsum H, Robinson K, Brattstrom L. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997; 277: 1775–1781
   PubMed Web of Science ®Google Scholar
• Whitmer R A, Haan M N, Miller J W, Yaffe K. Hormone replacement therapy and cognitive performance: the role of homocysteine. J Gerontol A Biol Sci Med Sci 2003; 58A: 324–329
   Google Scholar
• Prins N D, den Heijer T, Hofman A, et al. Homocysteine and cognitive function in the elderly: The Rotterdam Scan Study. Neurology 2002; 59: 1375–1380
   PubMed Web of Science ®Google Scholar
• Dufouil C, Alperovitch A, Ducros V, Tzourio C. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol 2002; 53: 214–221
   Web of Science ®Google Scholar
• Lehmann M, Gottfries C G, Regland B. Identification of cognitive impairment in the elderly: homocysteine is an early marker. Dementia Geriatric Cognitive Disorders 1999; 10: 12–20
   PubMed Web of Science ®Google Scholar
• Selhub J, Bagley L C, Miller J, Rosenberg I H. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 2000; 71: 614–620
   PubMed Web of Science ®Google Scholar
• Morris M S, Jacques P F, Rosenberg I H, Selhub J. Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001; 73: 927–933
   PubMed Web of Science ®Google Scholar
• Lipton S A, Kim W K, Choi Y B, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 1997; 94: 5923–5928
   PubMed Web of Science ®Google Scholar
• Diaz-Arrastia R. Hyperhomocystenemia: a new risk factor for Alzheimer's disease?. Arch Neurol 1998; 55: 1407–1408
   PubMed Web of Science ®Google Scholar
• Boushey C, Beresford S, Omenn G, Motulsky A. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049–1057
   PubMed Web of Science ®Google Scholar
• Rasouli M, Nasir K, Blumenthal R, Park R, Aziz D, Budoff M. Plasma homocysteine predicts progression of atherosclerosis. Atherosclerosis 2005; 181: 159–165
   PubMed Web of Science ®Google Scholar
• Wilson K, Lentz S. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models. Sem Vascular Med 2005; 5: 163–171
   PubMedGoogle Scholar
• Duthie S J, Whalley L J, Collins A R, Leaper S, Berger K, Deary I. Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 2002; 75: 908–913
   PubMed Web of Science ®Google Scholar
• Ravaglia G, Maioli F, Muscari A, et al. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr 2003; 77: 668–673
   PubMed Web of Science ®Google Scholar
• Elias M, Sullivan L, D'Agostino R, et al. Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am J Epidemiol 2005; 162: 644–653
   PubMed Web of Science ®Google Scholar
• Waldmann A, Koschizke J W, Leitzmann C, Hahn A. Homocysteine and cobalamin status in German vegans. Public Health Nutrition 2004; 7: 467–472
   PubMed Web of Science ®Google Scholar
• Strain J J, Dowey L, Ward M, Pentieva K, McNulty H. B-vitamins, homocysteine metabolism and CVD. Proc Nutr Soc 2004; 63: 597–603
   PubMed Web of Science ®Google Scholar
• Wolters M, Hermann S, Hahn A. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years. Eur J Nutr 2005; 44: 183–192
   PubMed Web of Science ®Google Scholar
• Ganji V, Kafai M R. Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 2003; 77: 826–833
   PubMed Web of Science ®Google Scholar
• Malouf R, Grimley E J, Areosa S A. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Systematic Rev 2003; 4
   Google Scholar
• Morris M S, Jacques P F, Selhub J, Rosenberg I H. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2000; 152: 140–148
   PubMed Web of Science ®Google Scholar
• Hak A E, Polderman K H, Westendorp I C, et al. Increased plasma homocysteine after menopause. Atherosclerosis 2000; 149: 163–168
   PubMed Web of Science ®Google Scholar
• Christodoulakos G E, Panoulis C P, Lambrinoudaki I V, Dendrinos S G, Rizos D A, Creatsas G C. Effect of hormone replacement therapy and tibolone on serum total homocysteine levels in postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2004; 112: 74–79
   PubMed Web of Science ®Google Scholar
• van Baal W M, Smolders R G, van der Mooren M J, Teerlink T, Kenemans P. Hormone replacement therapy and homocysteine levels. Obstet Gynecol 1999; 94: 485–491
   PubMed Web of Science ®Google Scholar
• Mijatovic V, Kenemans P, Jakobs C, van Baal W M, Peters-Muller E, van der Mooren M J. A randomized controlled study of the effects of 17 beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women. Obstet Gynecol 1998; 91: 432–436
   PubMed Web of Science ®Google Scholar
• Barnabei V M, Philips T M, Hsia J. Plasma homocysteine levels in women taking hormone replacement therapy: the postmenopausal estrogen/progestin interventions (PEPI) Trial. J Womens Health Gend Based Med 1999; 8: 1167–1172
   PubMedGoogle Scholar
• Farag N H, Barshop B A, Mills P J. Effects of estrogen and psychological stress on plasma homocysteine levels. Fertil Steril 2003; 79: 256–260
   PubMed Web of Science ®Google Scholar
• Evio S, Tiitinen A, Turpeinen U, Ylikorkala O. Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels. Fertil Steril 2000; 74: 1080–1083
   PubMed Web of Science ®Google Scholar
• Davison S, Davis S R. New markers for cardiovascular disease risk in women – impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab 2003; 88: 2470–2478
   PubMed Web of Science ®Google Scholar
• Marchesoni D, Driul L, Plaino L, Villani M T, Becagli L, Mozzanega B. Menopause rather than estrogen modifies plasma homocysteine levels. Int J Gynecol Obstet 2003; 81: 293–297
   PubMed Web of Science ®Google Scholar
• Chiantera V, Sarti C D, Fornaro F, et al. Long term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels. Menopause 2003; 10: 286–291
   PubMed Web of Science ®Google Scholar
• Cagnacci A, Malmusi S, Zanni A, Alessandrini C, Caretto S, Volpe A. Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels. Fertil Steril 2004; 81: 99–103
   PubMed Web of Science ®Google Scholar
• Smolders R G, van der Mooren M J, Sipkema P, Kenemans P. Estrogens, homocysteine, vasolidation and menopause: basic mechanisms, interactions and clinical implications. Gynecol Endocrinol 2003; 17: 339–354
   PubMed Web of Science ®Google Scholar
• van der Mooren M J, Mijatovic V, van Baal W M, Stehouwer C D. Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease. Maturitas 1998; 30: 27–36
   PubMed Web of Science ®Google Scholar
• Van der Mooren M J, Wouters M GAJ, Blom H J, Schellekens L A, Eskes T KAB, Rolland R. Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eur J Clin Invest 1994; 24: 733–736
   PubMed Web of Science ®Google Scholar
• Mijatovic V, Kenemans P, Netelenbos J C, et al. Postmenopausal oral 17-beta estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels. Fertil Steril 1998; 69: 876–882
   PubMed Web of Science ®Google Scholar
• Van der Mooren M J, Demacker P NM, Blom H J, De Rijke Y B, Rolland R. The effects of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women. Fertil Steril 1997; 67: 67–73
   PubMed Web of Science ®Google Scholar
• Albertazzi P, Di Micco R, Zanardi E. Tibolone: a review. Maturitas 1998; 30: 295–305
   PubMed Web of Science ®Google Scholar
• Celik H, Ayar A, Tug N, Cikim G, Kilie N, Parmaksiz C. Effects of tibolone on plasma homocysteine levels in postmenopausal women. Fertil Steril 2002; 78: 347–350
   PubMed Web of Science ®Google Scholar
• Barnes J F, Farish E, Rankin M, Hart D M. Effects of two continuous hormone therapy regimens on C-reactive protein and homocysteine. Menopause 2005; 12: 92–98
   PubMed Web of Science ®Google Scholar
• Yaffe K, Krueger K, Cummings S, et al. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial. Am J Psychiatry 2005; 162: 683–690
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Grady D, Sashegyi A, et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: 4-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) Randomized Trial. JAMA 2002; 287: 847–857
   PubMed Web of Science ®Google Scholar
• Smolders R G, Vogelvang T E, Mijatovic V, et al. A 2 year, randomized, comparative, placebo-controlled study on the effects of raloxifene in lipoprotein(a) and homocysteine. Maturitas 2002; 41: 105–114
   PubMed Web of Science ®Google Scholar
• Mijatovic V, Netelenbos J C, van der Mooren M J, de Valk-de Roo G, Jakobs C, Kenemans P. Randomized double blind placebo controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine in healthy postmenopausal women. Fertil Steril 1998; 70: 1085–1089
   PubMed Web of Science ®Google Scholar
• Walsh B W, Paul S, Wild R A, et al. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled study. J Clin Endocrinol Metab 2000; 85: 214–218
   PubMed Web of Science ®Google Scholar
• Moat S, McDowell I. Homocysteine and endothelial function in human studies. Semin Vasc Med 2005; 5: 172–182
   PubMedGoogle Scholar
• Kruman I, Culmsee C, Chan S, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000; 20: 6920–6926
   PubMed Web of Science ®Google Scholar
• Hankey G, Eikelboom J, Ho W, van Bockxmeer F. Clinical usefulness of plasma homocysteine in cardiovascular disease. Med J Aust 2004; 181: 314–318
   PubMed Web of Science ®Google Scholar
• Schafer J, Glass T, Bolla K, Mintz M, Jedlicka A, Schwartz B. Homocysteine and cognitive function in a population based study of older adults. J Am Geriatri Soc 2005; 53: 381–388
   PubMed Web of Science ®Google Scholar
• McCaddon A, Hudson P, Davies G. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001; 12: 309–313
   PubMed Web of Science ®Google Scholar
• Ravaglia G, Forti P, Maioli F, et al. Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J Nutrition, Health Aging 2000; 4: 218–222
   PubMedGoogle Scholar
• Kalmijn S, Launer L, Lindemans J, Bots M, Hofman A, Breteler M. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am J Epidemiol 1999; 150: 283–289
   PubMed Web of Science ®Google Scholar
• Somekawa Y, Kobayashi K, Tomura S, Aso T, Hamaguchi H. Effects of hormone replacement therapy and methylenetetrahydrofolate reductase polymorphism on plasma folate and homocysteine levels in postmenopausal Japanese women. Fertil Steril 2002; 77: 481–486
   PubMed Web of Science ®Google Scholar
• Yildirir A, Aybar F, Tokgozoglu L, et al. Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels. Gynecol Obstet Invest 2002; 53: 54–58
   PubMed Web of Science ®Google Scholar
• Ventura P, Cagnacci A, Malmusi S, Panini R, Baldassari F, Arangino S. Continuous combined hormone replacement therapy with oral 17 beta-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women. Menopause 2001; 8: 252–258
   PubMed Web of Science ®Google Scholar
• Hak A E, Bak A A, Lindemans J, et al. The effect of hormone replacement therapy on serum homocysteine levels in perimenopausal women: a randomized controlled trial. Atherosclerosis 2001; 158: 437–443
   PubMed Web of Science ®Google Scholar
• Vigna G, Donega P, Zanca R, et al. Simvastatin, transdermal patch and oral estrogen-progestogen preparation in early postmenopausal hypercholesterolemic women: a randomized placebo-controlled clinical trial. Metabolism 2002; 51: 1463–1470
   PubMed Web of Science ®Google Scholar
• De Leo V, Morgante G, Lanzetta D, Setacci C, Petraglia F. Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women. Am J Obstet Gynecol 2001; 184: 350–353
   PubMed Web of Science ®Google Scholar